TP
Therapeutic Areas
Sandia Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Anti-Her2 FluorAbody | HER2-positive Breast Cancer Diagnostics | Development |
| Anti-EphA2 FluorAbody | Cancer Research (e.g., Triple Negative Breast Cancer) | Research |
| Catalog Reagent Portfolio | Various Research & Diagnostic Applications | Commercial |